Xilio Therapeutics Inc.

NASDAQ: XLO · Real-Time Price · USD
0.80
-0.05 (-5.88%)
At close: May 15, 2025, 10:48 AM

Xilio Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for XLO stock have an median target of 4, with a low estimate of 4 and a high estimate of 4. The median target predicts an increase of 400.00% from the current stock price of 0.80.

Target Low Average Median High
Price 4 4 4 4
Change 400.00% 400.00% 400.00% 400.00%

Latest Analyst Insight Report

According to 1 stock analyst, the rating for Xilio Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Nov 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
51.87M
from 6.34M
Increased by 717.6%
Revenue Next Year
47.7M
from 51.87M
Increased by -8%
EPS This Year
-0.31
from -1.09
Increased by 71.6%
EPS Next Year
-0.67
from -0.31
Increased by -116.1%